erlotinib hydrochloride has been researched along with Dry Eye Syndromes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mohankumar, A; Ravisankar, R; Shivananda, N | 1 |
| Bao, J; Li, C; Shao, Y; Tan, G; Wu, AH; Yang, QC; Ye, L; Ye, LH; Zhou, Q | 1 |
2 other study(ies) available for erlotinib hydrochloride and Dry Eye Syndromes
| Article | Year |
|---|---|
Erlotinib-induced dry eye.
Topics: Dry Eye Syndromes; Erlotinib Hydrochloride; Humans; Lung Neoplasms | 2023 |
A murine model of dry eye induced by topical administration of erlotinib eye drops.
Topics: Administration, Topical; Animals; Cell Count; Cornea; Disease Models, Animal; Dry Eye Syndromes; Epidermal Growth Factor; Epithelium; Erlotinib Hydrochloride; Goblet Cells; Inflammation; Male; Mice, Inbred BALB C; Ophthalmic Solutions; Phosphorylation; Tears; Tumor Necrosis Factor-alpha | 2018 |